VK

Vikas Kanaiyalal Modi

Active Director Director DIN 05226864
DIN 05226864 First appointment Jun 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Jun 2016
Shareholding value •••• Premium profile

About Vikas Kanaiyalal Modi

Data last updated:

Vikas Kanaiyalal Modi is a Director at Shrim Pharma Private Limited (since 2016), Designated Partner at Ashtavinayak Medicals Llp (since 2018) and Director at Nephonc Biotech Private Limited (since 2020). The companies operate in Pharma, Chemicals and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹4.50 Cr; the largest is Shrim Pharma Private Limited at ₹3.89 Cr (FY 2025). Earlier, Vikas Kanaiyalal Modi was a Director at Quasar Hospitals Private Limited (2016–2018) and Director at Wellness Care Hospitals Private Limited (2016–2022).

DIN 05226864
Primary Designation Director
Industry Pharma
First Appointment 17 Jun 2016
Oldest Company Age 14 yrs
Largest company Shrim Pharma Private Limited · ₹3.89 Cr (FY 2025)
Combined revenue ₹4.50 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shrim Pharma Private Limited U52100MH2012PTC228795
Director03 Oct 20162012₹3.89 Cr (FY 2025)Active
Designated Partner19 Dec 20182018₹57.8 Lakh (FY 2026)Active
Nephonc Biotech Private Limited U24290GJ2020PTC119168
Director29 Dec 20202020₹3 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Quasar Hospitals Private Limited U85110MH2005PTC151554
Director01 Oct 20162005₹25.26 Cr (FY 2024)Active
Director17 Jun 20162016Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ashtavinayak Medicals Llp
Nephonc Biotech Private Limited
Shrim Pharma Private Limited
Quasar Hospitals Private Limited
Premium access

Shareholding and investment profile for Vikas Kanaiyalal Modi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vikas Kanaiyalal Modi

Vikas Kanaiyalal Modi currently holds 3 directorships: Shrim Pharma Private Limited (Director, since 03 Oct 2016, revenue ₹3.89 Cr (FY 2025)); Ashtavinayak Medicals Llp (Designated Partner, since 19 Dec 2018, revenue ₹57.8 Lakh (FY 2026)); Nephonc Biotech Private Limited (Director, since 29 Dec 2020, revenue ₹3 Lakh (FY 2025)).

Vikas Kanaiyalal Modi was first appointed on 17 Jun 2016 as Director at Wellness Care Hospitals Private Limited. The most recent appointment on record is 29 Dec 2020 at Nephonc Biotech Private Limited.

The 3 current companies of Vikas Kanaiyalal Modi that report revenue have a combined latest revenue of ₹4.50 Cr: Shrim Pharma Private Limited ₹3.89 Cr (FY 2025); Ashtavinayak Medicals Llp ₹57.8 Lakh (FY 2026); Nephonc Biotech Private Limited ₹3 Lakh (FY 2025).

Vikas Kanaiyalal Modi held 2 earlier board appointments: Quasar Hospitals Private Limited (Director, 01 Oct 2016 to 30 Sep 2018); Wellness Care Hospitals Private Limited (Director, 17 Jun 2016 to 26 Oct 2022).

The current boards of Vikas Kanaiyalal Modi's companies include Damyanti Vikas Modi (Shrim Pharma Private Limited), Shilpa Paresh Shah (Shrim Pharma Private Limited), Girishbhai Babubhai Akbari (Ashtavinayak Medicals Llp), Shailesh Devrajbhai Gajera (Ashtavinayak Medicals Llp), Hiral Harishbhai Dave (Nephonc Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available